USPTO Approved the Patent Application for OBI-888 “Antibodies, pharmaceutical compositions and uses thereof”

Contract Signing with Pharmacore for the Contract Manufacturing of OBI-858
September 25, 2017
Announcement on Change of the Accounting Officer
October 20, 2017
  1. Date of occurrence: October 6, 2017
  2. Company name: OBI Pharma Inc.
  3. Relationship to the Company (please enter ”head office” or ”affiliated company”): head office
  4. Reciprocal shareholding ratios: N/A
  5. Cause of occurrence: USPTO Granted OBI-888’s patent application on “Antibodies, pharmaceutical compositions and uses thereof” (Application No. 15 / 303,132)
  6. Countermeasures: None
  7. Any other matters that need to be specified: None